Lancet Neurol 5:525535
Of the 63 samples, SERMs were declared in 21 (33.3%), AIs in 16 (25.4%), and other PCT substances in 26 (41.3%)
And there is another issue around such peptides: Importantly, information regarding the indications, dosing, frequency and duration of treatment remains unknown, the researchers wrote
While this should logically increase the muscle-building effects, IGF-1 LR3 would also then bypass the internal feedback regulatory pathways, theoretically increasing the risk of negative side effects of excessive growth hormone pathway activity
Researchers frequently evaluate 5-Amino-1MQ within controlled laboratory environments where consistency, documentation, and standardized research procedures remain essential components of the scientific process
For scientific queries, contact the Clinical Trial Call Scientific Secretariat: [email protected]